Monday, October 20, 2025 from 8:00 a.m. to 9:30 a.m. CDT at Greenway ABCDE, 2nd Floor
This session is being recorded.
Learn MoreAvailable for 1.50 hours of CPE creditActivity Number: 0204-9999-25-212-L01-PActivity Type: An Application-Based ActivityRapid sequence intubation (RSI) is an emergency airway management strategy which requires support from an interdisciplinary team that includes providers, nurses, respiratory therapists, and pharmacists. Intubations can occur in a variety of settings and involve a variety of different disease states. Given the emergent nature of RSI, it is crucial to secure the airway as efficiently as possible, with choice of medications being one way to ensure intubation is performed in a safe and effective manner. This session will focus on the use of mainstay medications in RSI, induction agents and neuromuscular blocking agents, which assist with achieving first pass success.
This activity is approved for Board Certified Critical Care Pharmacist (BCCCP) and Emergency Medicine (BCEMP) Pharmacist recertification credit.
The BCCCP and BCEMP Clinical Sessions are part of the professional development program for the recertification of board-certified Critical Care or Emergency Medicine pharmacists by the Board of Pharmacy Specialties and jointly provided by ACCP and the American Society of Health-System Pharmacists (ASHP). In order to earn the BCCCP, BCEMP recertification credit, participants must attend the session, claim the continuing pharmacy education credit, and pass the associated posttest. Access to the Clinical Sessions posttests will be available on December 17, 2025, at www.accp.com/myaccount to anyone who has purchased access to the BCCCP/BCEMP posttests. For participants who have not purchased access to the posttests, access can be purchased until 1:00 p.m. on Tuesday, October 21, at the ACCP Registration Desk. The deadline to submit posttests for these sessions will be December 15, 2026.
Learning Objectives1. Select an optimal induction and paralytic agent for a patient using evidence-based guideline recommendations and recent literature.
2. Develop a pharmacotherapy plan to prevent and/or treat peri-intubation hypotension.
3. Given a patient case, choose the most appropriate paralytic reversal strategy.
 | | Speaker: | Jessica Nagy, Pharm.D., BCEMP, BCPS | | Clinical Pharmacist Specialist, Emergency Medicine
Rhode Island Hospital
Providence, RI | | View Biography |
|
 | | Speaker: | Lydia Ware, BCCCP, BCPS | | Clinical Pharmacy Specialist – Critical Care
Brigham and Women's Hospital
Boston, MA | | View Biography |
|